Inari Medical, Inc. (NARI) |
| 79.97 0 (0%) 02-18 16:00 |
| Open: | 79.96 |
| High: | 79.97 |
| Low: | 79.96 |
| Volume: | 2,356,692 |
| Market Cap: | 4,683(M) |
| PE Ratio: | -59.24 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 8.18 |
| Resistance 1: | 7.00 |
| Pivot price: | 6.85 |
| Support 1: | 6.65 |
| Support 2: | 6.43 |
| 52w High: | 79.99 |
| 52w Low: | 36.73 |
Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
| EPS | 0.800 |
| Book Value | 9.790 |
| PEG Ratio | 1.33 |
| Gross Profit | 4.209 |
| Profit Margin (%) | 21.14 |
| Operating Margin (%) | 91.25 |
| Return on Assets (ttm) | 2.2 |
| Return on Equity (ttm) | 8.5 |
Wed, 05 Aug 2026
NARI SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari - TMX Newsfile
Wed, 19 Feb 2025
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment - GlobeNewswire
Wed, 19 Feb 2025
Inari Medical, Inc. (NARI): the Best Performing Healthcare Stock So Far in 2025 - Yahoo Finance
Sat, 15 Feb 2025
Stryker Acquires Inari Medical: A $4.7 Billion Healthcare Merger (SYK, NARI) - tradingcalendar.com
Thu, 09 Jan 2025
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment - Florida Hospital News and Healthcare Report
Mon, 02 Dec 2024
Inari Medical Announces Joint Venture with 6 Dimensions Capital and VFLO Medical to Expand Access in Greater China - Quiver Quantitative
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |